Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
Department of Pharmacology and Pharmacy, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
J Gastroenterol Hepatol. 2024 Oct;39(10):2006-2017. doi: 10.1111/jgh.16664. Epub 2024 Jun 21.
Osteoporotic fracture is a prevalent noncommunicable disease globally, causing significant mortality, morbidity, and disability. As the population ages, the healthcare and economic burden of osteoporotic fracture is expected to increase further. Due to its multifactorial features, the development of osteoporotic fracture involves a complex interplay of multiple risk factors, including genetic, environmental, and lifestyle factors. Helicobacter pylori, which infects approximately 43% of the world's population, has been associated with increased fracture risk due to hypochlorhydria from atrophic gastritis and systemic inflammation from elevated pro-inflammatory cytokines. However, the potential impact of H. pylori infection and eradication on fracture risk remains contentious among various studies due to the study design and inadequate adjustment of confounding factors including baseline gastritis phenotype. In this review, we provided a comprehensive evaluation of the current evidence focusing on the underlying mechanisms and clinical evidence of the association between H. pylori infection and osteoporotic fracture. We also discussed the potential benefits of H. pylori eradication on fracture risk.
骨质疏松性骨折是一种在全球普遍存在的非传染性疾病,会导致严重的死亡率、发病率和残疾率。随着人口老龄化,骨质疏松性骨折的医疗保健和经济负担预计将进一步增加。由于其多因素的特点,骨质疏松性骨折的发生涉及多个风险因素的复杂相互作用,包括遗传、环境和生活方式因素。幽门螺杆菌感染了全球约 43%的人口,由于萎缩性胃炎导致胃酸过少和系统性炎症导致促炎细胞因子升高,与骨折风险增加有关。然而,由于研究设计和对包括基线胃炎表型在内的混杂因素的调整不足,幽门螺杆菌感染和根除对骨折风险的潜在影响在不同的研究中仍然存在争议。在这篇综述中,我们提供了对当前证据的全面评估,重点关注幽门螺杆菌感染与骨质疏松性骨折之间的关联的潜在机制和临床证据。我们还讨论了幽门螺杆菌根除对骨折风险的潜在益处。